Curaleaf raises Aurora Cannabis offer by 25%
Last updated: 01:05 06 Oct 2026 AEDT, First published: 00:05 06 Oct 2026 AEDT
Curaleaf Hldgs Inc. (OTCQX:CURLF), the Connecticut-based cannabis company, has raised its offer for Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB), a Canadian cannabis producer, by 25% to a total implied value of $5 per Aurora share in cash and stock.
The new price is 86% above Aurora's 30-day volume-weighted average share price of $2.75 as of August 10, the day before Curaleaf announced its intention to make its initial offer.
Aurora shareholders would receive 0.4013 Curaleaf shares plus $1 in cash for each Aurora share, with the cash portion up 33% and representing about 20% of the consideration.
Curaleaf also lifted the cap price, the maximum consideration per Aurora share, by 20% to $6, a 118% premium to Aurora's August 10 unaffected share price.
Boris Jordan, Curaleaf's chairman and chief executive, said the company improved the offer despite Aurora refusing to engage and provide access to customary due diligence, the review of a target's financial and legal records.
The enhanced proposal was developed solely from publicly available information, and Jordan urged Aurora's board to engage in good-faith discussions, saying shareholders deserve a fair and open process if other parties are being given access.
Jordan said Curaleaf has met with a significant percentage of Aurora's shareholders in recent weeks, all of whom support the strategic rationale for the deal.
A combined company would operate in 17 countries, with more than $1.5 billion of last-twelve-month revenue, nearly $350 million of last-twelve-month adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) and at least $40 million of expected annual cost synergies.
Curaleaf expects at least $40 million of annual cost savings and says the combined company, valued above $3 billion, would have a lower cost of capital than Aurora today.
The news sent shares of Aurora Cannabis around 16% higher in New York and Toronto on Monday morning.
Curaleaf shares were essentially flat at C$14.18 in Toronto.